| Macromolecular modeling and design in Rosetta: recent methods and frameworks JK Leman, BD Weitzner, SM Lewis, J Adolf-Bryfogle, N Alam, RF Alford, ... Nature methods 17 (7), 665-680, 2020 | 726 | 2020 |
| A practical guide to large-scale docking BJ Bender, S Gahbauer, A Luttens, J Lyu, CM Webb, RM Stein, EA Fink, ... Nature protocols 16 (10), 4799-4832, 2021 | 402 | 2021 |
| Protocols for molecular modeling with Rosetta3 and RosettaScripts BJ Bender, A Cisneros III, AM Duran, JA Finn, D Fu, AD Lokits, BK Mueller, ... Biochemistry 55 (34), 4748-4763, 2016 | 215 | 2016 |
| Structure, function and pharmacology of human itch GPCRs C Cao, HJ Kang, I Singh, H Chen, C Zhang, W Ye, BW Hayes, J Liu, ... Nature 600 (7887), 170-175, 2021 | 154 | 2021 |
| Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor Z Yang, S Han, M Keller, A Kaiser, BJ Bender, M Bosse, K Burkert, ... Nature 556 (7702), 520-524, 2018 | 138 | 2018 |
| Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex M Sharma, BJ Bender, JP Kamil, MF Lye, JM Pesola, NI Reim, JM Hogle, ... Journal of virology 89 (1), 523-534, 2015 | 81 | 2015 |
| Structural model of ghrelin bound to its G protein-coupled receptor BJ Bender, G Vortmeier, S Ernicke, M Bosse, A Kaiser, S Els-Heindl, ... Structure 27 (3), 537-544. e4, 2019 | 51 | 2019 |
| Modeling immunity with Rosetta: methods for antibody and antigen design CT Schoeder, S Schmitz, J Adolf-Bryfogle, AM Sevy, JA Finn, MF Sauer, ... Biochemistry 60 (11), 825-846, 2021 | 47 | 2021 |
| Improving homology modeling from low-sequence identity templates in Rosetta: A case study in GPCRs BJ Bender, B Marlow, J Meiler PLoS computational biology 16 (10), e1007597, 2020 | 45 | 2020 |
| Rosetta and the design of ligand binding sites R Moretti, BJ Bender, B Allison, J Meiler Computational Design of Ligand Binding Proteins, 47-62, 2016 | 39 | 2016 |
| Dynamic and nucleolin-dependent localization of human cytomegalovirus UL84 to the periphery of viral replication compartments and nucleoli BJ Bender, DM Coen, BL Strang Journal of virology 88 (20), 11738-11747, 2014 | 37 | 2014 |
| α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands M Sánchez-Soto, V Casadó-Anguera, H Yano, BJ Bender, NS Cai, ... Molecular neurobiology 55, 8438-8454, 2018 | 30 | 2018 |
| Improved in Vitro Folding of the Y2 G Protein-Coupled Receptor into Bicelles P Schmidt, BJ Bender, A Kaiser, K Gulati, HA Scheidt, HE Hamm, J Meiler, ... Frontiers in Molecular Biosciences 4, 100, 2018 | 25 | 2018 |
| A mutation deleting sequences encoding the amino terminus of human cytomegalovirus UL84 impairs interaction with UL44 and capsid localization BL Strang, BJ Bender, M Sharma, JM Pesola, RL Sanders, DH Spector, ... Journal of virology 86 (20), 11066-11077, 2012 | 24 | 2012 |
| The structural basis of peptide binding at class AG protein-coupled receptors O Vu, BJ Bender, L Pankewitz, D Huster, AG Beck-Sickinger, J Meiler Molecules 27 (1), 210, 2021 | 13 | 2021 |
| Modeling the complete chemokine–receptor interaction MJ Wedemeyer, BK Mueller, BJ Bender, J Meiler, BF Volkman Methods in cell biology 149, 289-314, 2019 | 13 | 2019 |
| Molecular basis for the evolved instability of a human G-protein coupled receptor LM Chamness, NB Zelt, HR Harrington, CP Kuntz, BJ Bender, WD Penn, ... Cell reports 37 (8), 2021 | 12 | 2021 |
| Comparative modeling and docking of chemokine-receptor interactions with Rosetta MJ Wedemeyer, BK Mueller, BJ Bender, J Meiler, BF Volkman Biochemical and biophysical research communications 528 (2), 389-397, 2020 | 4 | 2020 |
| Discovery of Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Using Ultralarge Virtual Screening ST Smith, JB Cassada, L Von Bredow, K Erreger, EM Webb, TA Trombley, ... ACS Pharmacology & Translational Science 7 (4), 1086-1100, 2024 | 3 | 2024 |
| Rosetta’s Predictive Ability for Low-Affinity Ligand Binding in Fragment-Based Drug Discovery E Okwei, ST Smith, BJ Bender, B Allison, S Ganguly, A Geanes, X Zhang, ... Biochemistry 62 (3), 700-709, 2023 | 3 | 2023 |